FDA Circular No. 2020-006-A || AMENDMENT TO FDA CIRCULAR NO. 2020-006 ENTITLED “GUIDANCE FOR APPLICATIONS AND TRANSACTIONS AT THE FOOD AND DRUG ADMINISTRATION IN LIGHT OF THE COMMUNITY QUARANTINE DECLARATION” ISSUED ON 17 MARCH 2020

The Food and Drug Administration (FDA) issued Circular No. 2020-006 entitled “Guidance for Applications and Transactions at the Food and Drug Administration in Light of the Community Quarantine Declaration” on 17 March 2020 as the Agency’s response to the Community Quarantine declaration.

The subsequent declaration of an Enhanced Community Quarantine (ECQ) prompted Local Government Units to impose lockdowns, including the proclamation of the City of Muntinlupa to place the city under twenty-four (24) hour curfew through Muntinlupa City Ordinance No. 2020-074. As a result, work from home scheme will be strictly implemented by the FDA to ensure continuity of government service during the period of Covid-19 outbreak to prevent further spread of the disease. Thus, modification and adjustment in the existing systems and procedures in the application for authorization is in order and hereby adopted.

This issuance aims to provide supplemental guidance relative to the interim changes in FDA’s work arrangement.

Read more:->FDA Circular No.2020-006-A

Related Circular:-> FDA Circular No. 2020-006

/ In Circular / By Administrator / Comments Off on FDA Circular No. 2020-006-A || AMENDMENT TO FDA CIRCULAR NO. 2020-006 ENTITLED “GUIDANCE FOR APPLICATIONS AND TRANSACTIONS AT THE FOOD AND DRUG ADMINISTRATION IN LIGHT OF THE COMMUNITY QUARANTINE DECLARATION” ISSUED ON 17 MARCH 2020
PHP Code Snippets Powered By : XYZScripts.com